-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Biogen (BIIB) Flexes Its Biotech Biceps
Biogen rallied nicely Wednesday, attacking technical resistance once more. This persistence should result in a major breakout of BIIB stock.
3 Healthcare Stocks to Treat Your Portfolio
As healthcare progresses in many ways, hospital management companies like Omega, HCA and LifePoint are some of the healthiest stocks to buy.
Great Biotech Stocks for Retirement Investors
Yes, Biotech stocks DO belong in your retirement portfolio. Here are three ways to add them and reap the rewards.
5 Red-Hot Biotech Stocks
The bricks are coming off the market's shoulders, and these five hot biotech stocks are among the top beneficiaries.
5 Low-Risk Healthcare Stocks to Buy
This list of five solid healthcare stocks features companies in the sweet spot between low risk and high return.
3 Best Defensive Funds to Protect Your Portfolio
The best defensive funds are ones that can provide decent returns in the latter stage of a bull market but also minimize losses when the bear is in full swing.
Hide Out from Volatility in … Biotech?
On April 19, Zafgen sold six million shares, one million more than initially planned.
Why You Must Sell Your Medical Marijuana Stocks NOW!
Federal regulators charge promoters with pumping and dumping PHOT and HEMP. Sell your medical marijuana stocks before it's too late.
4 Biotech Stocks to Buy
If this August is like most Augusts, the overall market isn't going to perform well for the next few weeks; biotech stocks may be the only worthwhile stocks to buy
Pfizer, Merck Stock – Same Ol’ Slumping Revenues, Same Mixed Prospects
The loss of exclusivity on blockbuster drugs continued to weigh in the top line at both Pfizer and Merck in the most recent quarter.
3 Reasons Why Biogen Stock Is Still a Buy (BIIB)
Janet Yellen might think biotech valuations are stretched, but the Street thinks companies like Biogen (BIIB) are just worth the growth
3 Ways to Play Healthcare’s Hot Stocks
Broad plays on healthcare stocks have done well historically, but investors can get some significant juice out of more targeted plays.
3 Biotech Stocks That Belong in Your Portfolio
The recent pullback in biotech stocks is an opportunity for investors to appeal to both growth and value in this dynamic sector.
Medical Marijuana Stocks Aren’t Worth the Price
Washington state's medical marijuana stores may be open for business, but that doesn't make medical marijuana stocks good investments.
Trade of the Day: United Cannibas Corp. (CNAB)
If you do go long, remember that a stop loss is always a good idea, especially for volatile marijuana stocks
3 Healthcare Stocks for Retirement Investors
Medical costs keep on rising. For investors in retirement, a dose of healthcare stocks could be the key to dealing with those costs.
Friend or Foe – Marijuana Stocks and the Tobacco Industry
Are medical marijuana companies stocks to buy now? Or should you be looking toward the potential future kings of marijuana -- Big Tobacco?
CLVS: Clovis Oncology Lung Cancer Drug Gets Breakthrough Therapy Designation
Clovis Oncology says the Food and Drug Administration has granted Breakthrough Therapy status to its new lung cancer drug, sending CLVS shares bouncing.
